Conference Coverage
Conference Coverage
Blood test for multiple cancers: Many false positives
“This technology is not ready for population-wide screening, but as the technology improves, costs will go down.”
News
Overall survival dips with vitamin D deficiency in melanoma
The research adds to existing evidence that “vitamin D levels can play an important and independent role in patients’ survival outcomes.”
Conference Coverage
New ESC cardio-oncology guideline aims to reduce cardiotoxicity
A “very strong theme throughout the guideline is risk assessment, and the fact that that risk is dynamic.”
Conference Coverage
Air pollution contribution to lung cancer may be underestimated
A study of women with lung cancer who never smoked suggests that air pollution may be a larger risk factor for lung cancer than currently...
Conference Coverage
Many die waiting for `last-chance’ therapy
Blood cancer patients, especially those with myeloma, face hospice and death while awaiting CAR T-cell therapy.
Conference Coverage
The shifting sands of lung cancer screening
Studies find encouraging trends of stage shifting and minority screening, but more work remains.
Conference Coverage
Pembrolizumab for melanoma bittersweet, doctor says
“Until we can further define who the highest-risk patients are, I think it’s hard to give it to everyone,” one doctor says.
Commentary
Drugging the undruggable
Targeted therapies are the ideal in drug development. New drugs that target KRAS (G12C) mutations mark a significant leap forward in oncology.
Conference Coverage
Select patients with breast cancer may skip RT after lumpectomy
There is “clearly a population of early-stage breast cancer [patients] who after lumpectomy do not benefit from radiation.”
Conference Coverage
Fatty liver disease drives rise in liver cancer deaths
The steep increase in liver cancer deaths is due to the rising rate of NAFLD and mostly driven by the obesity and type 2 diabetes epidemics.
